Wulff, Hansen & Co. Pfizer Inc Transaction History

Wulff, Hansen & Co.

$107 Million
Q2 2025

A detailed history of Wulff, Hansen & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Wulff, Hansen & Co. holds 12,280 shares of PFE stock, worth $302,824. This represents 0.28% of its overall portfolio holdings.

Number of Shares

12,280

Previous 10,119 21.36%

Holding current value

$302,824

Previous $256,000 16.02%

% of portfolio

0.28%

Previous 0.25%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$21.59 - $24.84 $46,655 - $53,679	2,161 Added 21.36%	12,280 $297,000
Q1 2025 May 14, 2025	BUY	$25.01 - $27.13 $20,133 - $21,839	805 Added 8.64%	10,119 $256,000
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $22,320 - $27,171	-900 Reduced 8.81%	9,314 $247,000
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $16,620 - $18,834	600 Added 6.24%	10,214 $295,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $6.55 Million - $7.68 Million	-259,386 Reduced 96.43%	9,614 $268,000
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $6.55 Million - $7.68 Million	259,386 Added 2698.0%	269,000 $7.53 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $562,657 - $730,830	-21,533 Reduced 69.13%	9,614 $276,000
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $24,742 - $28,626	-685 Reduced 2.15%	31,147 $1.14 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $1,878 - $2,452	-45 Reduced 0.14%	31,832 $1.63 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $15,783 - $19,558	345 Added 1.09%	31,877 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.3 Million - $1.93 Million	31,532 New	31,532 $1.86 Million

Others Institutions Holding PFE

# of Institutions

3,319

Shares Held

3.65B

Call Options Held

103M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wulff, Hansen & Co., based on Form 13F filings with the SEC.

News

Stay updated on Wulff, Hansen & Co. with notifications on news.

Account